Benign brain tumour - Clinical trials 

  • Clinical trials

Clinical trials for Benign brain tumour (non-cancerous)

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Benign brain tumour (non-cancerous). For all clinical trials, go to clinical trials search

This list shows clinical trials for Benign brain tumour (non-cancerous)

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Benign brain tumour (non-cancerous)
Title Recruitment status Location
An evaluation of the tolerability and feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with carmustine wafers (Gliadel) in the surgical management of primary Glioblastoma (GALA-5 Trial) Recruiting United Kingdom
Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH) Recruiting United Kingdom
Phase 1 trial of olaparib with temozolomide in relapsed glioblastoma Recruiting United Kingdom
Markers of Aggressive Local Therapy In Newly diagnosed Glioblastomas Recruiting United Kingdom
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma Not recruiting United Kingdom
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone - REGAL Not Recruiting United Kingdom
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour Not recruiting United Kingdom
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone - REGAL Not Recruiting United Kingdom
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib with Lomustine to the Efficacy of Lomustine Alone - REGAL Authorised United Kingdom
Treatment of children aged 3 to 18 years with newly diagnosed brain tumour (known as supratentorial high-grade glioma) using bevacizumab, an anti-angiogenic drug, added to conventional therapy (surgery, chemotherapy with temozolomide and radiation therapy) Authorised United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member